Phase 1-2 study on preventive effect of compression therapy using newly developed glove for oxaliplatin-induced peripheral neuropathy in colorectal cancer chemotherapy

Phase 1-2 study on preventive effect of compression therapy using newly developed glove for oxaliplatin-induced peripheral neuropathy in colorectal cancer chemotherapy - Study on preventive effect using newly developed glove for oxaliplatin-induced peripheral neuropathy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029671

Enrollment

Registered

2017-11-01

Start date

2017-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

newly developed glove

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients planning treatment with oxaliplatin 2) Patients who are over 20 years of age at consent acquisition 3) No gender 4) After receiving sufficient explanation for the participation of this study, patients who gained written consent by the patient's free will with sufficient understanding

Exclusion criteria

Exclusion criteria: 1) Patients with no peripheral neuropathy of Grade 1 or higher before starting the study 2) Patients who have not had a history of treatment with L-OHP in the past 3) Patients with disabilities or lesions difficult to wear gloves on the skin 4) Other Research Responsibilities (Sharing) Patients judged by doctors as inappropriate as subjects

Design outcomes

Primary

Measure	Time frame
Safety and effectiveness of new development glove	—

Countries

Japan

Contacts

Public ContactAkiyoshi Kanazawa

Shimane Prefectural Central Hospital Department of Surgery

kana@kuhp.kyoto-u.ac.jp0853-30-6590

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026